Joint Meeting of CMO and AMR - NFP Discussion and Conclusions

Post on 09-Jan-2016

21 views 1 download

Tags:

description

Joint Meeting of CMO and AMR - NFP Discussion and Conclusions. Marija Seljak, Director General of Public Health Ministry of Health. A ntimicrobial resistance remains one of the serious European and global health problem - PowerPoint PPT Presentation

Transcript of Joint Meeting of CMO and AMR - NFP Discussion and Conclusions

eu2008.si

Joint Meeting of CMO and AMR-NFP

Discussion and Conclusions

Marija Seljak, Director General of Public Health

Ministry of Health

• Antimicrobial resistance remains one of the serious European and global health problem

• In most MS between 2001 and 2005 an increase of the burden of antimicrobial resistance can be observed (EARSS)

• marked differences in AB use between EU countries and in the types of AB that are used

• consistent association between the level of use of certain AB and resistance to these AB has been reported confirming the suspected relationship between AB use and AMR in EU countries

• Recommendations on prudent use of antimicrobials in human medicine adopted in 2001

• MS, European Commission and EU agencies (ECDC, EFSA, EMEA,…) have taken variety of actions

•What are the areas of the Recommendations where the actions need to be improved?

Need for…

• developing national strategy with translation to action plan

• ensuring ownership at the local level

Need for…

• Setting up inter-sectorial mechanism, e.g. a national committee, involving all relevant stakeholders with the clear mandate and political support

Need for…

• Strengthening surveillance systems and data quality on antimicrobial resistance, use of antimicrobial agents and healthcare-associated infections

Need for…

• Promoting good hygiene practices for the control of the transmission multidrug resistance bacteria

Need for…

• Promoting prudent use of antibiotics through awareness campaigns with credible, scientifically based messages and actions, aimed at the practitioners and general public and include information about the risk of self-medication

Need for at EU level…

• Follow – up on the implementation of Council Recommendations

• Continue with “Health in all policies approach” in this area through EU initiatives

Need for at EU level

• Continue with activities within the ECDC in this area (country visits, recommendations, scientific work, surveillance)

• Exchange of best practices among MS• Antibiotic Awareness Day

eu2008.si

HVALA!THANK YOU!